Sanofi SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning, good afternoon, and good evening, everybody. And thank you for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs.
Bill, thank you so much for joining us. It's my pleasure to welcome Bill Sibold, who is Executive Vice President, Head of Sanofi Genzyme and also a member of the Executive Committee at Sanofi. Bill, once again, thank you so much for your time, and thank you for joining us.
Before we move to kind of Q&A session, Bill, I don't know if you want to make a few introductory comments kind of on some of the recent kind of data sets you guys have presented, what are you seeing in the business? And then we can take it to Q&A from that.
Sure. That's great. Well thank you, Keyur, and thank you, everyone, for joining. It's a real pleasure to be here, though I certainly wish that we were all live in California.
We've been making great progress in our Play to Win
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
